Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.8983 per EA under NDC 59651097360. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
75 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651097360
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208039On Market Since
5/14/2025
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 17.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8983 per EA |
|---|---|
| All-time high | $1.0929 (Jan 14, 2026) |
| All-time low | $0.8478 (Apr 22, 2026) |
| 52-week high | $1.0929 |
| 52-week low | $0.8478 |
| Median price | $0.9423 |
| Average price | $0.9680 |
| Largest weekly change | -10.0% (Apr 22, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Aurobindo Pharma Limited, is $0.8983 per EA (NDC 59651097360), effective Jun 24, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 17.8%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Dec 17, 2025, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8478 (Apr 22, 2026) to a high of $1.0929 (Jan 14, 2026), with a median of $0.9423 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DABIGATRAN ETEXILATE 75 MG CAP, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 59651097360) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification